RFK Jr. remains firmly in place as HHS Secretary more than 18 months into the Trump administration, with recent department announcements on mental health funding and weed management initiatives underscoring his ongoing role. Rumors of disengagement or an early exit surfaced in mid-2026 but were promptly denied by HHS officials and allies, including CMS Administrator Mehmet Oz, with no supporting evidence of resignation plans or White House pressure. Kennedy has continued public defense of his record and policy priorities on vaccines, chronic disease, and agency restructuring, while facing routine congressional oversight rather than acute calls for removal. These factors, combined with historical patterns of cabinet stability absent major scandals or policy reversals, underpin trader consensus that he will serve through year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado$24,291 Vol.
$24,291 Vol.
$24,291 Vol.
$24,291 Vol.
An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Mercado Aberto: Mar 19, 2026, 2:02 PM ET
Resolver
0x65070BE91...An announcement of Robert F. Kennedy Jr. (RFK Jr.)'s resignation/removal before this market's end date will immediately resolve this market to "Yes", regardless of when the announced resignation/removal goes into effect.
The resolution source for this market will be official information from Robert F. Kennedy Jr. (RFK Jr.) and the U.S. government; however, a consensus of credible reporting may also be used.
Resolver
0x65070BE91...RFK Jr. remains firmly in place as HHS Secretary more than 18 months into the Trump administration, with recent department announcements on mental health funding and weed management initiatives underscoring his ongoing role. Rumors of disengagement or an early exit surfaced in mid-2026 but were promptly denied by HHS officials and allies, including CMS Administrator Mehmet Oz, with no supporting evidence of resignation plans or White House pressure. Kennedy has continued public defense of his record and policy priorities on vaccines, chronic disease, and agency restructuring, while facing routine congressional oversight rather than acute calls for removal. These factors, combined with historical patterns of cabinet stability absent major scandals or policy reversals, underpin trader consensus that he will serve through year-end.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado



Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions